Description
This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and techniques have evolved from steady improvements, including the use of antibiotic materials, biosensors, wireless communications, and more efficient pumps and controllers. These new developments have stabilized the market and maintained a consistent market competition. Increasingly favorable epidemiology and demographics make the outlook for additional applications and concomitant market growth quite good. Growth and development of ancillary markets in nutritional supplementation, both consumer driven and clinical, are also building interest in this sector.
In addition to a thorough discussion of the drivers and constraints in the current market, the briefing provides forecasts through 2008 for the following market data:
- Number of patients using medical nutritional supplements by product type (oral enteral, enteral tube, parenteral)
- Revenues for enteral and parenteral nutritional supplements by type of facility (home/alternate site vs hospital/acute care)
- Revenues for enteral and parenteral nutritional supplements by route of administration (oral enteral, enteral tube, parenteral)
Market data and forecasts are based on an examination of current market conditions, current and projected demographics, and on investigations into the development of new products by key companies. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with various stakeholders in the clinical nutrition industry, including company executives, clinicians, insurers, regulators, researchers, and public health officials.
Table of Contents
Chapter One: Executive Summary
- Scope and Methodology
- Summary of Major Findings
Chapter two: Introduction
- The Food and Nutrient Spectrum
- Nutraceuticals and Unconventional Foods
- Functional Foods
- Medical Food and Federal Laws
- Food and Nutritional Products in the Consumer Marketplace
- Probiotic Foods
- The Weight Control Industry
- Medical Conditions Most Likely to Require Nutritional Support
- Cancer
- Cancer and Diet
- Cancer and Weight Loss
- Nutritional Support of Cancer Treatment
- Nutrition Support in the Dying Patient
- Vegetative States
- Nutritional Management in Chylous Leaks
- Acquired Immune Deficiency Syndrome
- Nutritional Support in Burn Injury
- Pulmonary Disease
- Diabetes Mellitus
Chapter Three: Methods of Nutritional Support
- Choosing a Method for Nutritional Support
- Enteral Feeding
- Oral Ingestion
- Strategies for Tube Feeding
- Hormone Response to Enteral Feeding and Choice of Materials
- Products Used for Enteral Feeding
- Management of Enteral Feeding
- Parenteral Nutrition
- Intravenous Feeding
- Container Sizing
- Total Parenteral Nutrition
- Basic Parameters for TPN
- Amino Acids
- Lipids
- Carbohydrates
- Minerals and Trace Materials
Chapter Four: Medical Nutrition Market and Forecasts
- Summary of Nutritional Products and Procedures
- Enteral Nutritional Support
- Parenteral Nutrition
- Advantages of Nutritional Support
- Factors Contributing to a Changing Medical Nutrition Market
- An Ageing Patient Population
- Greater Emphasis on Weight Control
- Health Care Insurance
- Home Care and Alternate Site Care
- Market Size and Forecasts
- Segmentation by Type of Facility
- Segmentation by Type of Route of Administration
- Distribution Channels
Chapter Five: Company & Organization Profiles
- Abbott Laboratories
- Alaris Medical Systems, Inc..
- American Gastroenterological Association
- American HomePatient, Inc.
- American Society For Parenteral & Enteral Nutrition (ASPEN)
- Arrow International
- Astrazeneca PLC
- B. Braun Medical Inc.
- Baxter International Inc.
- Bristol-Myers Squibb Company
- Fresenius Kabi
- Fujisawa Pharmaceutical Company, Ltd.
- Hospira Inc. (Subsidiary of Abbott Laboratories)
- Kendall Healthcare Products
- Mead Johnson Nutritional Group (a subsidiary of Bristol-Myers Squibb)
- Nestlé Nutrition
- Novartis Medical Nutrition
- Oley Foundation
- Ross Products Division of Abbott Laboratories
- Sandoz Incorporated
- SHS North America
- Wyeth Pharmaceuticals
- ZEVEX International, Inc.
list of exhibits
Chapter One: Executive Summary
- Exhibit 1: Total Market Summary: U.S. Clinical Nutrition Products
- Market 2001-2008
Chapter two: Introduction
- Exhibit 2: Technical Definitions of Medical Food
- Exhibit 3: Disease States That Benefit Most from Nutritional Supplementation
- Exhibit 4: Distribution of Patients Currently Using Long-Term Nutritional Supplementation in the Home or Long-Term Setting Percentage of Total by Condition and Type of Supplementation (Enteral vs Parenteral)
Chapter Three: Methods of Nutritional Support
- Exhibit 5: Clinical Decision Algorithm: Route of Nutrition Support
- Exhibit 6: Indications and Contraindications for Enteral Feeding
- Exhibit 7: Disease-Specific Enteral Nutrition for Inborn Errors of Metabolism Exhibit 8: Medicare Part B Rates for the Four Categories of ROSS Nutritional Products (2004)
- Exhibit 9: Conditions for Which Parenteral May Be Indicated
- Exhibit 10: Advantages and Disadvantages of TPN
- Exhibit 11: AMA Recommendations for Use of TPN
Chapter Four: Medical Nutrition Market and Forecasts
- Exhibit 12: Number of Patients using Medical Nutritional Supplements by Product Type 2001-2008
- Exhibit 13: Distribution of Clinical Nutritional Supplement Patiens by Product Type 2001-2008
- Exhibit 14: Important Growth Factors Affecting the Parenteral Nutrition Solution Market
- Exhibit 15: Important Restrictions Affecting to the Parenteral Nutrition Solution Market
- Exhibit 16: The U.S. Market for Enteral and Parenteral Nutritional Supplements by Type of Facility (Home/Alternate Site vs Hospital/Acute Care) 2001-2008
- Exhibit 17: Ditribution of U.S. Enteral and Parenteral Nutritional Supplement Sales by Type of Facility 2001-2008
- Exhibit 18: The U.S. Market for Enteral and Parenteral Nutritional Supplements by Route of Administration (Oral Enteral, Enteral Tube, Parenteral) 2001-2008
